White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example

Health technology assessments and value frameworks are becoming increasingly important for clinical decision-making. Most of these frameworks, however, focus on value to payers rather than patients and healthcare providers and may ignore other sources of economic value such as patient and physician...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackisch, Christian, Manevy, Federico, Frank, Suzanne, Roberts, Nicki, Shafrin, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730478/
https://www.ncbi.nlm.nih.gov/pubmed/34988876
http://dx.doi.org/10.1007/s12325-021-01996-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730478/
https://www.ncbi.nlm.nih.gov/pubmed/34988876
http://dx.doi.org/10.1007/s12325-021-01996-0

Ejemplares similares